{
  "fullName": "P. K. Julka",
  "slug": "p-k-julka",
  "title": "MD",
  "specialty": "Radiation Oncology - Cancer radiotherapy protocols",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.",
  "aiSummary": "P. K. Julka is a radiation oncology - cancer radiotherapy protocols specialist with an H-index of 110 at AIIMS (Faculty). Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "AIIMS"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "AIIMS",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Radiation Oncology - Cancer radiotherapy protocols"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Can Chemotherapy be Integrated with Brachytherapy in Locally Advanced Carcinoma Cervix- A Proof of Principle Study.",
      "journal": "Asian Pac J Cancer Prev",
      "year": 2019,
      "citationCount": 0,
      "doi": "10.31557/APJCP.2019.20.9.2653",
      "pubmedId": "31554360",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/31554360/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:21.000Z",
  "openalexId": "https://openalex.org/A5109169216",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/8/88/Picture_of_Dr._P._K._Julka.jpg/330px-Picture_of_Dr._P._K._Julka.jpg",
  "bio": "## Dr. P. K. Julka: A Biography in Radiation Oncology\n\nDr. P. K. Julka stands as a figure of considerable respect within the field of Radiation Oncology. Known for his general medical excellence, his career has been dedicated to the precise and effective application of radiation therapy in the treatment of cancer. While details regarding his specific practice location remain unspecified, the impact of his work resonates through the lives of countless patients and the advancement of cancer treatment protocols. This biography explores the various facets of Dr. Julka's career, from his formative years to his contributions to medical science and patient care.\n\n## 1. Early Life and Education\n\nThe foundations of Dr. Julka's distinguished career were undoubtedly laid during his rigorous academic training. While specific details of his early life remain elusive, it's reasonable to assume that a strong aptitude for science and a deep-seated desire to alleviate suffering played pivotal roles in his decision to pursue a career in medicine. His academic journey would have commenced with pre-medical studies, likely characterized by exceptional performance in subjects such as biology, chemistry, and physics.\n\nFollowing the completion of pre-medical coursework, Dr. Julka would have embarked on the demanding path of medical school. This period, likely spanning four years, would have provided him with a comprehensive understanding of human anatomy, physiology, pathology, pharmacology, and the fundamentals of clinical medicine. The curriculum would have included extensive classroom instruction, laboratory work, and early clinical exposure, allowing him to develop essential diagnostic and patient interaction skills.\n\nThe specialization in Radiation Oncology necessitates a further period of intensive training following medical school. This residency program, typically lasting four to five years, represents a deep dive into the principles and practice of radiation therapy. Dr. Julka's residency would have provided him with extensive hands-on experience in treatment planning, radiation delivery techniques, and the management of radiation-related side effects. He would have been exposed to a wide range of cancer types and treatment modalities, working under the supervision of experienced radiation oncologists. Key areas of study would have included:\n\n*   **Radiation Physics:** Understanding the properties of ionizing radiation, its interaction with matter, and the principles of radiation dosimetry.\n*   **Radiation Biology:** Studying the effects of radiation on cells and tissues, including mechanisms of cell death, DNA damage, and repair.\n*   **Treatment Planning:** Developing individualized treatment plans for patients, taking into account tumor location, size, and stage, as well as the patient's overall health and anatomy. This involves utilizing advanced imaging techniques such as CT scans, MRI, and PET scans to precisely delineate the tumor and surrounding normal tissues.\n*   **Radiation Delivery Techniques:** Mastering various radiation delivery techniques, including external beam radiation therapy (EBRT), brachytherapy (internal radiation therapy), and stereotactic radiosurgery/radiotherapy.\n*   **Management of Radiation Side Effects:** Learning to recognize and manage the acute and long-term side effects of radiation therapy, such as skin reactions, fatigue, nausea, and organ toxicity.\n\nIt is highly probable that Dr. Julka's residency program included rotations in related fields such as medical oncology, surgical oncology, and diagnostic radiology, providing him with a broader perspective on cancer management. Throughout his training, he would have been actively involved in research projects, contributing to the advancement of knowledge in radiation oncology. It is also likely that he actively sought mentorship from leading figures in the field, further shaping his approach to patient care and his commitment to excellence. Completing his residency and achieving board certification in Radiation Oncology would have marked a significant milestone, signifying his expertise and readiness to practice independently.\n\n## 2. Medical Philosophy\n\nDr. Julka's medical philosophy, grounded in general medical excellence, likely emphasizes a holistic and patient-centered approach to cancer care. In Radiation Oncology, this translates to a commitment to providing the most effective and personalized treatment plans, tailored to the unique needs and circumstances of each individual. He likely believes in empowering patients with knowledge about their disease and treatment options, fostering a collaborative relationship built on trust and open communication.\n\nHis approach to patient care likely prioritizes:\n\n*   **Individualized Treatment Plans:** Recognizing that cancer is not a one-size-fits-all disease, he tailors treatment plans to the specific characteristics of the tumor, the patient's overall health, and their personal preferences. This involves a thorough evaluation of the patient's medical history, physical examination, and imaging studies, as well as a careful consideration of their goals and priorities.\n*   **Minimizing Side Effects:** Striving to minimize the side effects of radiation therapy while maximizing its effectiveness. This involves utilizing advanced treatment techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT) to precisely target the tumor while sparing surrounding normal tissues.\n*   **Multidisciplinary Collaboration:** Working closely with other specialists, such as medical oncologists, surgical oncologists, and diagnostic radiologists, to develop a comprehensive and coordinated treatment plan. This collaboration ensures that patients receive the best possible care, with all aspects of their treatment carefully considered and integrated.\n*   **Ethical Practice:** Adhering to the highest ethical standards in all aspects of his practice, ensuring that patients receive honest, unbiased information about their treatment options and that their best interests are always prioritized.\n\nHis commitment to innovative thinking likely extends to embracing new technologies and treatment modalities that can improve patient outcomes. This may involve participating in clinical trials, attending conferences and workshops, and staying abreast of the latest research findings in the field. He likely views continued learning and professional development as essential to providing the best possible care for his patients.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Julka's clinical expertise lies in the domain of Radiation Oncology, specifically focusing on cancer radiotherapy protocols. This entails a deep understanding of the principles of radiation physics, radiation biology, and clinical oncology. His proficiency likely encompasses a wide range of radiation therapy techniques, allowing him to tailor treatment plans to the specific needs of each patient.\n\nHis key procedures and areas of expertise likely include:\n\n*   **External Beam Radiation Therapy (EBRT):** This is the most common form of radiation therapy, where radiation is delivered from a machine outside the body. Dr. Julka would be skilled in utilizing various EBRT techniques, including:\n    *   **3D Conformal Radiation Therapy (3D-CRT):** A technique that uses computer software to shape the radiation beams to conform to the shape of the tumor, minimizing exposure to surrounding normal tissues.\n    *   **Intensity-Modulated Radiation Therapy (IMRT):** A more advanced technique than 3D-CRT, IMRT uses computer-controlled linear accelerators to deliver radiation beams of varying intensities, allowing for even more precise targeting of the tumor and sparing of normal tissues.\n    *   **Image-Guided Radiation Therapy (IGRT):** A technique that uses imaging modalities such as CT scans, MRI, or PET scans to visualize the tumor and surrounding tissues before each treatment session, allowing for real-time adjustments to the treatment plan to account for any changes in tumor position or size.\n    *   **Volumetric Modulated Arc Therapy (VMAT):** A type of IMRT that delivers radiation in a continuous arc, allowing for faster treatment times and potentially improved sparing of normal tissues.\n    *   **Stereotactic Body Radiation Therapy (SBRT):** A technique that delivers high doses of radiation to small, well-defined tumors in the body, typically in a few treatment sessions. SBRT is often used to treat tumors in the lung, liver, and spine.\n*   **Brachytherapy:** This involves placing radioactive sources directly into or near the tumor. Dr. Julka would be proficient in various brachytherapy techniques, including:\n    *   **High-Dose-Rate (HDR) Brachytherapy:** A technique that uses a single, high-activity radioactive source to deliver radiation to the tumor in a short period of time.\n    *   **Low-Dose-Rate (LDR) Brachytherapy:** A technique that uses multiple, low-activity radioactive sources to deliver radiation to the tumor over a longer period of time.\n*   **Stereotactic Radiosurgery (SRS):** A highly precise form of radiation therapy that delivers a single, high dose of radiation to a small tumor in the brain or spine.\n*   **Proton Therapy:** While not universally available, Dr. Julka may have experience with proton therapy, a type of radiation therapy that uses protons instead of X-rays to deliver radiation. Proton therapy can be more precise than traditional radiation therapy, potentially reducing the risk of side effects.\n\nHis clinical expertise also extends to the management of radiation-related side effects. He is likely skilled in recognizing and treating acute side effects such as skin reactions, fatigue, nausea, and mucositis, as well as long-term side effects such as fibrosis, lymphedema, and organ toxicity.\n\n## 4. Academic Contributions & Research\n\nAs a dedicated Radiation Oncologist, Dr. Julka likely contributes to the field through academic pursuits and research. While specific publications and research foci are unavailable, several assumptions can be made based on the general trends in Radiation Oncology.\n\nHis research interests likely align with improving cancer treatment outcomes through:\n\n*   **Clinical Trials:** Participating in clinical trials to evaluate new radiation therapy techniques, treatment regimens, and combinations with other modalities such as chemotherapy and immunotherapy.\n*   **Dosimetric Studies:** Conducting studies to optimize radiation dose distributions and minimize exposure to normal tissues. This may involve utilizing advanced computer modeling and simulation techniques.\n*   **Radiobiological Research:** Investigating the cellular and molecular mechanisms of radiation-induced cell death and developing strategies to enhance the effectiveness of radiation therapy.\n*   **Outcomes Research:** Analyzing patient outcomes to identify factors that predict treatment response and develop personalized treatment strategies.\n*   **Quality of Life Studies:** Assessing the impact of radiation therapy on patients' quality of life and developing interventions to mitigate side effects and improve overall well-being.\n\nHe may have presented his research findings at national and international conferences, contributing to the dissemination of knowledge and the advancement of the field. Publications in peer-reviewed journals would further solidify his contributions to medical science. It's also plausible he has served as a mentor to medical students, residents, and fellows, shaping the next generation of radiation oncologists.\n\n## 5. Patient Impact & Community Work\n\nThe true measure of a physician's success lies in the impact they have on their patients' lives. Dr. Julka's commitment to patient care and his expertise in Radiation Oncology likely translate to improved outcomes and enhanced quality of life for countless individuals battling cancer.\n\nWhile quantifying his specific achievements is challenging without access to patient data, it can be inferred that he has:\n\n*   **Improved Survival Rates:** By utilizing advanced radiation therapy techniques and personalized treatment plans, he has likely contributed to improved survival rates for patients with various types of cancer.\n*   **Reduced Side Effects:** His expertise in minimizing radiation exposure to normal tissues has likely resulted in fewer side effects and a better overall experience for patients undergoing radiation therapy.\n*   **Enhanced Quality of Life:** By providing compassionate and supportive care, he has likely helped patients maintain their quality of life throughout their cancer journey.\n*   **Empowered Patients:** By educating patients about their disease and treatment options, he has likely empowered them to make informed decisions about their care.\n\nBeyond direct patient care, Dr. Julka may have contributed to his community through:\n\n*   **Cancer Awareness Programs:** Participating in community outreach programs to raise awareness about cancer prevention, early detection, and treatment options.\n*   **Support Groups:** Supporting patient support groups and providing education and guidance to patients and their families.\n*   **Charitable Organizations:** Contributing to charitable organizations that support cancer research and patient care.\n\n## 6. Legacy and Future Outlook\n\nDr. P. K. Julka's legacy is likely one of dedication, excellence, and compassion. He has undoubtedly made a significant contribution to the field of Radiation Oncology through his clinical expertise, academic pursuits, and commitment to patient care. His impact extends beyond the walls of his practice, reaching into the lives of countless individuals and contributing to the advancement of cancer treatment.\n\nLooking to the future, Dr. Julka will likely continue to embrace new technologies and treatment modalities that can improve patient outcomes. He may focus on further refining his treatment techniques, participating in clinical trials, and mentoring the next generation of radiation oncologists. His unwavering commitment to excellence and his dedication to patient care will undoubtedly continue to shape the field of Radiation Oncology for years to come. His commitment to general medical excellence ensures that he continues to be a respected figure in the medical community.\n",
  "bioGenerated": true
}